GlassScriptPhysician profile
Deeanne Seeger
NPI 1447517917
$6,229.21
in general payments reported to CMS, 2019-2025
12 companies · $780 in 2025
The $780 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $644 · 2022: $2,814 · 2023: $921 · 2024: $1,071 · 2025: $780.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,616 · Travel and Lodging: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,616.37 |
| Travel and Lodging | $155.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $3,573.14 | 2021-2025 | Carto 3 |
| Janssen Pharmaceuticals, INC | $614.35 | 2021-2023 | Xarelto |
| Medtronic, INC. | $578.91 | 2021-2025 | Cobalt Dr Mri Surescan, Mycarelink, Micra |
| Impulse Dynamics (USA) INC. | $498.43 | 2023-2024 | Optimizer, Optimizer |
| E.R. Squibb & Sons, L.L.C. | $217.38 | 2021-2025 | Eliquis |
| Boston Scientific Corporation | $191.30 | 2022-2025 | Watchman |
| Pfizer INC. | $153.16 | 2024-2025 | |
| Medical Device Business Services, INC. | $151.58 | 2024 | Carto 3 |
| Elutia, INC. | $146.64 | 2021 | |
| Atricure, INC. | $44.86 | 2023 | |
| Sanofi-Aventis U.S. LLC | $38.12 | 2022 | |
| Philips North America LLC | $21.34 | 2024 | (Am5) Lead Management |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deeanne Seeger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.